Company intelligence / Profile preview

LNP Therapeutics

Wilmington, Delaware, United States

Ownership: Private
Development stage: Other

Overview

LNP Therapeutics is a biotechnology company focused on developing next-generation lipid nanoparticle (LNP) delivery systems for nucleic acid-based therapeutics. The company's primary mission is to overcome the current limitations of LNP technology, such as tissue specificity and immunogenicity, to enable the delivery of mRNA and other RNA modalities to extra-hepatic tissues. By optimizing the chemical composition of lipids, LNP Therapeutics aims to expand the reach of genetic medicines across various therapeutic areas, including oncology and rare genetic disorders.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Lipid nanoparticle delivery therapymRNA-based drugsRNA therapy
Industry: Biotech

Beyond the preview

Go deeper on LNP Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LNP Therapeutics.

Explore the full profile